Cargando…
Open Clinical Trial Data for All? A View from Regulators
Hans-Georg Eichler from the European Medicines Agency and colleagues provide a view from regulators on access to clinical trial data.
Autores principales: | Eichler, Hans-Georg, Abadie, Eric, Breckenridge, Alasdair, Leufkens, Hubert, Rasi, Guido |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3323505/ https://www.ncbi.nlm.nih.gov/pubmed/22505851 http://dx.doi.org/10.1371/journal.pmed.1001202 |
Ejemplares similares
-
Pharmacovigilance 2030: Invited Commentary for the January 2020 “Futures” Edition of Clinical Pharmacology and Therapeutics
por: Arlett, Peter, et al.
Publicado: (2019) -
FDA Facilitated Regulatory Pathways: Visualizing Their Characteristics, Development, and Authorization Timelines
por: Liberti, Lawrence, et al.
Publicado: (2017) -
How to Get All Trials Reported: Audit, Better Data, and Individual Accountability
por: Goldacre, Ben
Publicado: (2015) -
Clinical Trials for COVID‐19: Can we Better Use the Short Window of Opportunity?
por: Eichler, Hans‐Georg, et al.
Publicado: (2020) -
The Open Translational Science in Schizophrenia (OPTICS) project: an open-science project bringing together Janssen clinical trial and NIMH data
por: Wilcox, Marsha A., et al.
Publicado: (2018)